While levels of phospho-IGF-1R did not correlate with drug sensitivity, the sensitive NSCLC cell lines displayed high levels of total IGF-1R and higher copy numbers (Gong et al., 2009). Here, IGF1R is linked to non-small cell lung carcinoma.